The company rapidly profiles molecular targets. Drug companies use its tests.
LCMS Laboratories will provide clinical diagnostic and test-development services.
Bag It provides information information to newly diagnosed patients.
Oro Valley company names new president.
The Tucson area’s main economic-development agency has adopted a new strategic “blueprint” with a goal of creating nearly 40,000 new jobs in the next five years.
Pima Community College’s newest building has three floors, a legion of laboratory skeletons and a $12.5 million price tag.
Gov. Jan Brewer was in Oro Valley on Tuesday to tour two of the area’s biggest biotech employers, and she came away impressed.
Tucson’s technology sector had its share of highs and lows in 2013. Here’s a look at some of the top local tech stories of 2013, in no particular order, and what to look for in the coming year.
Oro Valley-based Ventana Medical Systems, part of the Roche Group, has published positive findings for a test the company has developed to detect lesions that can be precursors to cervical cancer.
Some sales and marketing employees of Ventana Medical Systems in Oro Valley have been laid off or moved as the result of a restructuring of parent company Roche, the company confirmed.
While many college students will spend this summer catching some waves, some University of Arizona students are catching the next wave in medicine.
The Leukemia & Lymphoma Society's Team in Training program and Ventana Medical Systems Inc. are joining to deliver a morning of inspiration and information Saturday.
Can a satellite-guided bullet be far behind? In recent years, Tucson-based Raytheon Missile Systems has increasingly focused on developing smaller precision-guided weapons, including the 3 1/2-foot-long Griffin missile and its two-foot Pyros small tactical munition.
Oro Valley-based Ventana Medical Systems said it is introducing a first-of-its-kind, fully-automated sample staining technique that will allow researchers to examine two key indicators related to cancer in the same section of tumor tissue.
If Larry Mehren's vision becomes a reality, Tucson could be home to a technology that could revolutionize the treatment of bacterial infections.
A Denver company is moving to Tucson with ambitious growth plans and hopes of creating a biotech hub to attract scientists and engineers.